Literature DB >> 1444927

Cataract extraction in eyes filled with silicone oil.

J Moisseiev1, E Bartov, M Cahane, M Blumenthal, G Treister.   

Abstract

A surgical technique for cataract extraction in eyes filled with silicone oil was developed that has two major objectives: removal of the entire cataractous lens and complete preservation of the silicone oil volume. A regular extracapsular cataract extraction or phacoemulsification is performed, and the incision is closed with the final sutures. All steps are performed under continuous positive pressure achieved with an anterior chamber maintainer connected to a bottle of balanced saline solution. An inferior basal iridectomy is created with a vitrectomy probe, and the posterior capsule is then slowly pulled out through the limbal incision with intraocular forceps, again under positive pressure, in an eye that is actually a closed system, without any loss of silicone. This step results in transformation of the extracapsular cataract extraction condition into an intracapsular cataract extraction condition. The described technique was successfully performed in nine eyes. In the younger patients, the whole procedure was completed through two very small limbal openings.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1444927     DOI: 10.1001/archopht.1992.01080230149040

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  3 in total

1.  Mechanical energy from intraocular instruments cause emulsification of silicone oil.

Authors:  Jasmine H Francis; Paul A Latkany; Jeanne L Rosenthal
Journal:  Br J Ophthalmol       Date:  2006-10-11       Impact factor: 4.638

2.  Vitreous Substitutes.

Authors:  William Joseph Foster
Journal:  Expert Rev Ophthalmol       Date:  2008-04

3.  Biometry and refractive outcome of eyes filled with silicone oil by standardized echography and partial coherence interferometry.

Authors:  Johannes Nepp; Katharina Krepler; Kerstin Jandrasits; Wolfgang Hauff; Georg Hanselmayer; Michaela Velikay-Parel; Karl C Ossoinig; Andreas Wedrich
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-10-20       Impact factor: 3.117

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.